AmerisourceBergen Stock To Go Ex-dividend Tomorrow (ABC)

NEW YORK ( TheStreet) -- The ex-dividend date for AmerisourceBergen (NYSE: ABC) is tomorrow, May 17, 2012. Owners of shares as of market close today will be eligible for a dividend of 13 cents per share. At a price of $36.48 as of 9:30 a.m. ET, the dividend yield is 1.4%.

The average volume for AmerisourceBergen has been 2.8 million shares per day over the past 30 days. AmerisourceBergen has a market cap of $9.27 billion and is part of the services sector and wholesale industry. Shares are down 2.1% year to date as of the close of trading on Tuesday.

AmerisourceBergen Corporation, a pharmaceutical services company, provides drug distribution and related services to healthcare providers and pharmaceutical manufacturers primarily in the United States and Canada. The company has a P/E ratio of 14, equal to the average wholesale industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates AmerisourceBergen as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full AmerisourceBergen Ratings Report.

See our dividend calendar or top-yielding stocks list.

null

More from Markets

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Your Worst Enemy In a Bear Market Is Yourself

Your Worst Enemy In a Bear Market Is Yourself

Economist Perspective: Brexit Endgame in Sight?

Economist Perspective: Brexit Endgame in Sight?

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge